← Open Payments lookup

MANUEL JIMENEZ: Open Payments

NPI 1619412350 · SUNNYSIDE, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$884 in 38 payments from 11 companies in 2025. Trend: 2023 $642 · 2024 $397 · 2025 $884

Food & beverage: $884
CompanyPaymentsAmount
AstraZeneca Pharmaceuticals LP7$223
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)10$157
Lilly USA, LLC4$110
Sumitomo Pharma America, Inc.4$104
Novo Nordisk Inc3$69
Bayer Healthcare Pharmaceuticals Inc.2$52
KYOWA KIRIN, INC.3$52
Otsuka America Pharmaceutical, Inc.2$48
Novartis Pharmaceuticals Corporation1$26
PFIZER INC.1$23

Products named: CAPLYTA, MOUNJARO, GEMTESA, FARXIGA, Kerendia, CRYSVITA, REXULTI, ENTRESTO.

Industry payments across WA — which companies pay providers there.